Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rinaldo Zurbriggen

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Chemistry & Biology|May 26, 2007
Structure-activity-based design of a synthetic malaria peptide eliciting sporozoite inhibitory antibodies in a virosomal formulationShinji L Okitsu, Ursula Kienzl, Kerstin Moehle, et al.
Plos One|December 7, 2007
A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trialShinji L Okitsu, Olivier Silvie, Nicole Westerfeld, et al.
Cancer Letters|February 23, 2008
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccinePierpaolo Correale, Maria Teresa Del Vecchio, Tommaso Renieri, et al.
Plos One|July 30, 2011
Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & childrenPatrick Georges Cech, Thomas Aebi, Mwanajaa Shomari Abdallah, et al.
Vaccine|June 14, 2003
Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residentsArie Ben-Yehuda, Aviva Joseph, Yechezkel Barenholz, et al.
Immunity|February 15, 2011
Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challengesMorgane Bomsel, Daniela Tudor, Anne-Sophie Drillet, et al.
Plos One|January 31, 2008
Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trialFiona M Thompson, David W Porter, Shinji L Okitsu, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Chemistry & Biology|May 26, 2007
Structure-activity-based design of a synthetic malaria peptide eliciting sporozoite inhibitory antibodies in a virosomal formulationShinji L Okitsu, Ursula Kienzl, Kerstin Moehle, et al.
Plos One|December 7, 2007
A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trialShinji L Okitsu, Olivier Silvie, Nicole Westerfeld, et al.
Cancer Letters|February 23, 2008
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccinePierpaolo Correale, Maria Teresa Del Vecchio, Tommaso Renieri, et al.
Plos One|July 30, 2011
Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & childrenPatrick Georges Cech, Thomas Aebi, Mwanajaa Shomari Abdallah, et al.
Vaccine|June 14, 2003
Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residentsArie Ben-Yehuda, Aviva Joseph, Yechezkel Barenholz, et al.
Immunity|February 15, 2011
Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challengesMorgane Bomsel, Daniela Tudor, Anne-Sophie Drillet, et al.
Plos One|January 31, 2008
Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trialFiona M Thompson, David W Porter, Shinji L Okitsu, et al.
Pageof 4